Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
基本信息
- 批准号:10515913
- 负责人:
- 金额:$ 67.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-12 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdvertisingAffectAlcohol abuseAreaAttitudeBeliefBisexualCancer BurdenCancer PatientCancer SurvivorCaringClinicClinic VisitsComparative StudyComputerized Medical RecordConceptionsCybersexDataData SourcesDevelopmentDiscriminationEthnic OriginExclusionFaceFemaleGaysGenderGender IdentityHIVHeterosexualsIntervention TrialInterviewLesbian Gay Bisexual TransgenderLiteratureMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMental HealthMethodologyMethodsMinority Health ResearchPatient RecruitmentsPatientsPerformancePersonsPopulationPrimary PreventionProfessional OrganizationsProtocols documentationRaceRehabilitation therapyReportingResearchResearch PersonnelSamplingSecond Primary CancersSex OrientationSexual and Gender MinoritiesShapesSiteSmokingSocial supportStructureSubgroupSurveysSurvivorsTelephoneTestingTimeTreatment outcomeUnderserved PopulationUnited States National Institutes of HealthWomanWorkWorkloadadvanced diseaseanticancer researchbasecancer carecancer health disparitycancer riskcancer therapycancer typecare deliverycis-femalecis-malecisgendercomparison groupcostdesigneffectiveness testingevidence baseexperiencegender minoritygender minority grouphealth disparityinformantintersectionalitymalemenminority stressneglectnovelpatient populationpatient stratificationperceived discriminationpreventrecruitresearch studysatisfactionsexsexual minoritysexual minority mensexual minority womensocialsocial stigmasociodemographicssuccesstheoriestransgenderwillingness
项目摘要
Abstract
Recently, NCI called for research to effectively study small or rare populations relevant to cancer research.
Sexual and gender minorities (SGM) are small populations at disproportionate risk for cancer but who have
been under-researched in cancer studies. The principal challenge common across lesbian, gay, bisexual, and
transgender populations is to develop effective methods to identify and recruit patients and survivors who are
SGM into NCI cancer studies. Two technical advances have transformative potential to advance research on
health disparities in SGM cancer patients. First, online recruitment has yielded large SGM samples in other
areas of research (e.g., HIV primary prevention), but using online methods to recruit SGM cancer patients has
not been rigorously studied. Second, cancer clinics have begun to include sexual orientation and gender
identity (SOGI) data in the electronic medical record, but we need to test protocols on how to recruit SGM
cancer patients using this data source. This application is based upon our recent success in overcoming
challenges to recruit over 400 gay and bisexual prostate cancer patients into an R01 intervention trial of
tailored rehabilitation for this population. We will replicate and expand upon these clinic-based and online
methods to study how to recruit three small SGM populations – (1) sexual minority cisgender men, (2) sexual
minority cisgender women, and (3) transgender and gender non-binary cancer patients - into cancer research
studies. We have three specific aims. In Aim 1, we will document, in depth, SGM’s attitudes towards
participating in NIH cancer research, identifying the facilitators and barriers that each group reports influences
their willingness to participate. We will also investigate any impact poor cancer care and discrimination has on
research participation. We will investigate these in cisgender SM men, cisgender SM women and gender
minority cancer patients (n=15 per group) and compare experiences within these small populations and
between SGM and a cisgender, heterosexual patient comparison group. In Aim 2, we will test the
effectiveness, efficiency, cost, and workload in using two clinic SOGI-based strategies and three online
strategies to recruit SGM small populations (150 each) compared to recruiting a sample of cisgender,
heterosexual cancer patients. We predict size of the small population will negatively correlate with work, cost,
and time involved, but positively correlate with yield. In Aim 3, we will conduct an online quantitative survey of
willingness to participate in cancer research with 450 SGM cancer patients (150 per group) versus a cisgender
heterosexual group (150 men and 150 women). Key measures assess facilitators and barriers to participation
in NIH cancer research. To advance measures, we will assess performance of each group on five validated
cancer scales to compare cancer care experience, discrimination in treatment, and outcomes. Finally, we will
integrate and triangulate findings and assess intersectionality with race/ethnicity. This study will establish what
recruitment strategies are effective across SGM populations, and which may be specific to each subgroup.
摘要
最近,NCI呼吁研究有效地研究与癌症研究相关的小或罕见人群。
性和性别少数群体(SGM)是癌症风险不成比例的小群体,但他们
在癌症研究中研究不足。女同性恋、男同性恋、双性恋和
跨性别人群是制定有效的方法来识别和招募患者和幸存者谁是
SGM进入NCI癌症研究。两项技术进步具有推动研究的变革潜力,
SGM癌症患者的健康差异。首先,在线招聘在其他国家产生了大量的SGM样本,
研究领域(例如,艾滋病毒初级预防),但使用在线方法招募SGM癌症患者,
没有被严格研究过。其次,癌症诊所已经开始将性取向和性别纳入其中
身份(SOGI)数据在电子病历,但我们需要测试协议,如何招募SGM
癌症患者使用此数据源。此应用程序基于我们最近成功克服
招募400多名同性恋和双性恋前列腺癌患者参加R 01干预试验的挑战
为这一人群量身定制的康复方案。我们将复制和扩展这些基于诊所和在线的
研究如何招募三个小SGM人群的方法-(1)性少数顺性别男性,(2)性
少数cisgender妇女,和(3)跨性别和性别非二元癌症患者-进入癌症研究
问题研究我们有三个具体目标。在目标1中,我们将深入记录SGM对
参与NIH癌症研究,确定每个小组报告影响的促进因素和障碍
他们的参与意愿。我们还将调查贫困的癌症护理和歧视对
研究参与。我们将调查这些在顺性SM男性,顺性SM女性和性别
少数癌症患者(每组n=15),并比较这些小人群的经验,
SGM和一个顺性别、异性恋患者对照组之间的差异。在目标2中,我们将测试
使用两种基于诊所SOGI的策略和三种在线策略的有效性、效率、成本和工作量
与招募顺性别样本相比,招募SGM小群体(每个群体150人)的策略,
异性恋癌症患者我们预测小人口的规模将与工作,成本,
与产量呈正相关。在目标3中,我们将进行一项网上定量调查,
450例SGM癌症患者(每组150例)与顺性别患者相比,
异性恋组(150名男性和150名女性)。关键措施评估促进者和参与障碍
在NIH癌症研究中。为了推进措施,我们将评估每个小组在五个有效的
癌症量表,比较癌症护理经验,治疗歧视和结果。最后我们将
综合和三角调查结果,并评估与种族/族裔的交叉性。这项研究将确定什么
招募策略在SGM人群中有效,并且可能对每个亚组具有特异性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
B R Simon Rosser其他文献
B R Simon Rosser的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('B R Simon Rosser', 18)}}的其他基金
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
- 批准号:
10771387 - 财政年份:2022
- 资助金额:
$ 67.99万 - 项目类别:
Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
培训长期服务和支持痴呆症护理人员,为性少数群体居民提供护理
- 批准号:
10523826 - 财政年份:2022
- 资助金额:
$ 67.99万 - 项目类别:
Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
培训长期服务和支持痴呆症护理人员,为性少数群体居民提供护理
- 批准号:
10703475 - 财政年份:2022
- 资助金额:
$ 67.99万 - 项目类别:
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
- 批准号:
10683296 - 财政年份:2022
- 资助金额:
$ 67.99万 - 项目类别:
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
恢复:改善同性恋和双性恋前列腺癌幸存者的性结果
- 批准号:
9980806 - 财政年份:2017
- 资助金额:
$ 67.99万 - 项目类别:
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
恢复:改善同性恋和双性恋前列腺癌幸存者的性结果
- 批准号:
9528534 - 财政年份:2017
- 资助金额:
$ 67.99万 - 项目类别:
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
恢复:改善同性恋和双性恋前列腺癌幸存者的性结果
- 批准号:
10206046 - 财政年份:2017
- 资助金额:
$ 67.99万 - 项目类别:
Understanding the Effects of Prostate Cancer on Gay and Bisexual Men
了解前列腺癌对男同性恋和双性恋男性的影响
- 批准号:
8927565 - 财政年份:2014
- 资助金额:
$ 67.99万 - 项目类别:
Understanding the Effects of Prostate Cancer on Gay and Bisexual Men
了解前列腺癌对男同性恋和双性恋男性的影响
- 批准号:
8767750 - 财政年份:2014
- 资助金额:
$ 67.99万 - 项目类别:
Men's INTernet Study III (MINTS-III) for HIV Prevention
预防艾滋病毒的男性互联网研究 III (MINTS-III)
- 批准号:
8444676 - 财政年份:2010
- 资助金额:
$ 67.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 67.99万 - 项目类别:
Research Grant














{{item.name}}会员




